Protein C Antigen Test Kit

An enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Protein C Antigen in citrated human plasma.



Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Product Features

Protein C is a vitamin K-dependent protein synthesized primarily by hepatocytes in the liver and plays an important physiologic role in the Protein C Anticoagulant System.1,2 Protein C, thrombin from blood clots, and endothelial cells, through complex interactions with other factors of the coagulation cascade, contribute to the maintenance of normal hemostatic mechanisms by down-regulating clot formation and by promoting fibrinolysis. The Protein C Anticoagulant System is activated by the binding of thrombin to thrombomodulin, a transmembrane protein receptor on endothelial cells.3 The thrombin-thrombomodulin binding on endothelial cell membranes activates circulating Protein C. Activated Protein C binds to Protein S on the membrane of endothelial cells or platelets. In this Protein C-Protein S complex, activated Protein C is now capable of inactivating coagulation factors Va and VIIIa, down-regulating clot formation. Activated Protein C also enhances the function of tissue plasminogen activator (TPA) by dissociating this molecule from its inhibitor, plasminogen activator inhibitor-1 (PAI-1), thereby facilitating clot dissolution or fibrinolysis.1-3

Protein C deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism.4 Patients with a congenital heterozygous deficiency may present with venous thrombosis in young adulthood, while patients with the rare homozygous deficiency present with massive thrombosis (purpura fulminans) during the neonatal period.5 The prevalence of Protein C deficiency in the general population has been estimated at 1 in 300. In younger patients (<40-45 years) with recurrent venous thrombosis, the frequency of Protein C deficiencies may be as high as 10 to 15%.6-7 Acquired Protein C deficiency may be seen in liver disease, extensive thrombotic episodes, surgery, oral anticoagulant therapy, antiphospholipid syndrome, etc. A decreased Protein C activity in plasma may be the result of low concentrations and function (type I) or only low function (type II).6

The laboratory diagnosis of Protein C deficiency may require both quantitative and qualitative (functional) determinations. Quantitative determinations of Protein C Antigen are based on immunologic procedures such as radial immunodiffusion in gel, Laurell rocket immunoelectrophoresis and enzyme-linked immunosorbent assay (ELISA).6,8 ELISA procedures are less labor intensive and offer several advantages including more objective, accurate and reproducible results. In addition, ELISA allows automation with commonly available laboratory instruments.

Techical Sheet / Info

The Protein C Antigen assay is a sandwich ELISA. A capture antibody specific for human Protein C is coated to 96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells, allowing any available Protein C to bind to the anti-human Protein C antibody on the microwell surface. The plates are washed to remove unbound proteins and other plasma molecules. Bound Protein C is quantitated using horseradish peroxidase (HRP) conjugated anti-human Protein C detection antibody. Following incubation, unbound conjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogen peroxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in optical density (O.D.) units with a spectrophotometer at 450nm. Protein C Antigen relative percent concentrations in patient plasma are determined against a curve prepared from the reference plasma provided with the kit.

Order Enquiry

Order Enquiry Form

References
  1. Kisiel W. Human plasma Protein C. Isolation, characterization, mechanism of activation by α-Thrombin. J Clin Invest 64:761-769, 1979.
  2. Clouse LH, Comp PC. The regulation of hemostasis: The Protein C System. N Engl J Med 314:1298-1304, 1986.
  3. Stenflo J. Structure and function of Protein C: Semin Thromb Haemost 10:109-121, 1984.
  4. Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of Protein C in congenital thrombotic disease. J Clin Invest 68:13701373, 1981.
  5. Tollefson DFJ, Friedman KD, et al. Protein C Deficiency: A cause of unusual or unexplained thrombosis. Arch Surg 123:881-884, 1988.
  6. Preissner KT. Biological relevance of the Protein C system and laboratory diagnosis of Protein C and S deficiencies. Clin Science 78:351-364, 1990.
  7. Griffin JH, Evatt B, Wideman C, et al. Anticoagulant Protein C Pathway defective in majority of thrombophilic patients. Blood 82:1989-1993, 1993.
  8. Miletich JP. Laboratory diagnosis of Protein C deficiency. Semin Thromb Haemost 16:169-176, 1990.
Documents
Enquiry